Xeroderma Pigmentosum (XP)

🧠 Standard of Care & Symptoms

Xeroderma Pigmentosum (XP) is a rare, life-threatening autosomal recessive genetic disorder characterized by an extreme sensitivity to ultraviolet (UV) radiation and a severely impaired ability to repair UV-induced DNA damage.

• Presentation: Key diagnostic signs.
  • *Severe Sunburn:* Extreme, painful blistering sunburn after minimal sun exposure (as little as a few minutes) in early infancy.
  • *Early Lentigines:* Abundant, dark freckle-like spots (lentigines) on sun-exposed areas (face, neck, forearms) appearing before age 2.
  • *Cutaneous Malignancies:* Extremely high risk (over 10,000-fold increase) of developing basal cell carcinomas, squamous cell carcinomas, and melanomas in childhood.
  • *Ocular Pathology:* Photophobia, corneal clouding, vascularization, ectropion, and neoplastic growths on the eyelids and conjunctiva.
  • *Neurological Degeneration:* Progressive cognitive decline, sensorineural hearing loss, spasticity, and ataxia, occurring in about 25% of cases (primarily complementation groups A and D).

🧬 Diagnostics & DNA Repair Pathophysiology

Diagnosis requires clinical recognition of photosensitivity, genetic sequencing of XP complementation genes, and cellular assays evaluating DNA repair activity.

• Diagnostic Markers: Key criteria.
  • Genetic Testing: Confirms mutations in one of the eight genes responsible: *XPA, XPB (ERCC3), XPC, XPD (ERCC2), XPE (DDB2), XPF (ERCC4), XPG (ERCC5)*, or the variant form *POLH* (encoding DNA polymerase eta).
  • Unscheduled DNA Synthesis (UDS) Assay: Performed on cultured skin fibroblasts. Measures the uptake of radioactively labeled thymidine after UV radiation, directly quantifying the rate of DNA repair. Deficient UDS confirms XP.
  • Frequent Clinical Screening: Skin evaluations every 1 to 3 months are required to detect and treat skin cancers at the earliest pre-malignant or micro-invasive stages.

Pathophysiology of Nucleotide Excision Repair Failure

The cellular damage and carcinogenesis in XP are caused by a breakdown in the cell's DNA proofreading systems:

• Nucleotide Excision Repair (NER) Pathway: In healthy individuals, the NER pathway identifies and cuts out DNA damage caused by UV radiation, primarily **cyclobutane pyrimidine dimers (CPDs)** and **6-4 photoproducts**.
• XP Complementation Groups: Deficiencies in any of the XPA through XPG proteins prevent the recognition, unwinding, or cutting of damaged DNA strands. The variant form (XP-V, *POLH* mutation) lacks DNA polymerase eta, which is required to replicate past unrepaired dimers during cell division.
• Rapid Carcinogenesis: Unrepaired CPDs cause permanent transitions (specifically C→T and CC→TT transitions) during DNA replication. This high mutation rate rapidly inactivates tumor suppressor genes (like p53) and activates oncogenes, triggering early-onset skin cancers.

💊 UV Protection & Chemoprevention

The standard of care centers on absolute avoidance of UV radiation and oral chemoprevention to reduce the rate of new skin cancers.

Absolute UV Protection

• Complete Environmental Shielding: Patients must live in UV-protected environments. Windows in homes, cars, and schools must be covered with UV-blocking films. Broad-spectrum SPF 50+ sunscreen, UV-blocking face shields, wide-brimmed hats, and protective suits are required for any outdoor exposure.
• Indoor Light Safety: Avoid halogen and fluorescent lights, which emit low levels of UV radiation. Utilize LED lighting, which is safe.

Chemoprevention & Surgical Care

• Oral Retinoids (Isotretinoin/Acitretin): High-dose oral retinoids are used to prevent the development of new skin cancers. Retinoid therapy requires careful monitoring for side effects, including skeletal toxicity, dry skin, and teratogenicity.
• Topical DNA Repair Enzymes: Investigational topical creams containing **T4 endonuclease V** encapsulated in liposomes are designed to penetrate cells and assist in repairing pyrimidine dimers in the skin.
• Aggressive Tumor Excision: Any suspicious lesion must undergo immediate biopsy and surgical excision, Mohs micrographic surgery, or cryotherapy.

🔬 Active Clinical Trials

Clinical trials are evaluating topical DNA repair enzymes, systemic chemopreventive agents, and specialized UV-blocking clothing designs.

🗺️ Next Steps After Diagnosis

If you or your child has been diagnosed with Xeroderma Pigmentosum, establish these clinical care pathways:

1. Perform a Home UV Audit: Use a digital UV light meter to check all windows, light bulbs, and environments to ensure zero UV exposure.
2. Apply Window Films: Immediately install museum-grade UV-blocking film on all windows in your home and vehicles.
3. Establish Dermatological Visits: Schedule routine skin cancer checks with a pediatric dermatologist every 1 to 3 months.
4. Consult an Ophthalmologist: Obtain specialized UV-blocking glasses and schedule regular eye exams.

❓ Patient FAQ

Q: Can children with XP go outside during the day?
A: Yes, but only with absolute protection: a full-body UV-protective suit, gloves, a face shield, and broad-spectrum sunscreen. Many families choose to adjust their sleep schedules to turn their active hours to the night to avoid sunlight entirely.

Q: Is Xeroderma Pigmentosum hereditary?
A: Yes, XP is inherited in an autosomal recessive pattern. Both parents must carry one copy of the mutated gene. The parents usually do not show symptoms, but each child they have has a 25% chance of developing XP.